hg_61001.1

Basic information about the TSS

---

TSS ID: hg_61001.1 Species: human Chr: chr5		Start: 16465793 End: 16465808 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000308683.3 NM_033414 Distance: 0 GeneID: 90441 HGNC/MGI_ID: HGNC:30958 UniProt_ID: Q969S3

Gene_name: zinc finger protein 622 Gene_symbol: ZNF622 Gene_synonyms: MGC17552 MGC2485 ZPR9 Gene_source: HGNC:30958

TATA-Box annotation

---

Distance to TSS:	-1
Nearest PromoterID:	NM_033414
Entrez ID:	90441
Nearest Unigene:	Hs.60300
Nearest Refseq:	NM_033414
Nearest Ensembl:	ENSG00000173545
Gene Name:	zinc finger protein 622
Gene Alias:	ZPR9
Gene Description:	zinc finger protein 622
Gene Type:	protein-coding
CpG%:	0.07
GC%:	0.621891
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ZNF622 p2@ZNF622
Sample		p1@ZNF622	p2@ZNF622
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	25.13	6.04
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	29.13	9.10
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	25.66	7.91
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	28.69	8.11
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	30.60	8.77
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	31.20	6.40
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	28.54	10.89
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	21.80	10.42
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	28.21	11.33
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	49.85	12.17
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	49.72	7.28
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	50.82	9.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	6.61	5.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	5.86	7.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	6.15	5.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.31	3.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	6.77	5.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	5.06	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	5.86	5.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	6.47	6.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.29	6.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	9.84	6.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.66	5.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	10.92	7.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.74	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.81	8.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.44	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	11.08	9.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	9.53	4.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.40	5.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.47	6.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	11.72	4.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.71	6.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.33	7.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	11.41	5.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	12.65	5.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	13.49	5.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	13.30	7.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	15.13	4.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.08	6.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	10.12	4.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.23	6.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.54	3.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	13.46	5.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.64	7.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	11.86	7.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	8.64	5.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	10.13	5.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	10.29	4.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.72	4.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	10.25	4.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	8.23	5.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	195.89	55.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	6.03	6.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.96	5.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	41.11	25.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	17.45	11.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	11.67	10.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.35	6.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	14.77	9.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	6.35	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.17	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.92	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.51	5.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.55	6.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.71	5.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	118.46	55.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	5.36	4.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	4.46	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.10	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	8.61	4.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.26	4.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	6.73	3.67
Adipocyte - breast, donor1	11376-118A8	27.40	14.10
Adipocyte - breast, donor2	11327-117E4	16.36	9.63
Adipocyte - omental, donor1	11473-119C6	18.58	11.07
Adipocyte - omental, donor2	11474-119C7	10.46	11.96
Adipocyte - omental, donor3	11475-119C8	10.05	6.70
Adipocyte - perirenal, donor1	11476-119C9	14.04	10.21
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	15.36	7.68
Adipocyte - subcutaneous, donor3	11408-118E4	11.99	8.52
Adipocyte differentiation, day04, donor1	13019-139D4	17.99	10.95
Adipocyte differentiation, day04, donor2	13022-139D7	14.41	11.07
Adipocyte differentiation, day04, donor3	13025-139E1	12.54	11.15
Adipocyte differentiation, day04, donor4	13028-139E4	10.58	7.05
Adipocyte differentiation, day08, donor1	13020-139D5	12.87	11.02
Adipocyte differentiation, day08, donor2	13023-139D8	12.26	11.30
Adipocyte differentiation, day08, donor3	13026-139E2	18.13	8.53
Adipocyte differentiation, day08, donor4	13029-139E5	12.24	10.02
Adipocyte differentiation, day12, donor1	13021-139D6	9.57	9.15
Adipocyte differentiation, day12, donor2	13024-139D9	10.55	4.52
Adipocyte differentiation, day12, donor3	13027-139E3	9.82	4.58
Adipocyte differentiation, day12, donor4	13030-139E6	10.35	4.26
Alveolar Epithelial Cells, donor1	11510-119G7	18.78	11.71
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	4.66
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	14.57	10.43
Amniotic Epithelial Cells, donor2	11613-122A2	16.73	6.69
Amniotic Epithelial Cells, donor3	11694-123A2	16.23	9.66
Anulus Pulposus Cell, donor1	11248-116E6	15.79	11.44
Anulus Pulposus Cell, donor2	11463-119B5	9.55	10.78
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	18.87	10.33
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	16.93	9.55
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	19.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	15.84	8.37
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	16.44	10.12
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.18	7.92
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.17	9.75
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	13.11	11.17
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	10.69	9.50
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	16.95	9.42
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	12.34	4.35
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	20.06	10.03
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	18.94	11.20
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	12.28
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	12.52	9.20
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.15	11.79
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.60	10.20
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	16.04	8.29
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	18.53	4.88
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.24	8.46
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	6.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	15.78	10.12
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	13.11	11.16
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	17.83	10.25
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	29.07	9.69
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.39	10.83
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	15.18	10.47
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.90	8.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	14.55	7.98
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.15	10.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	10.70	6.42
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.28	8.19
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	14.15	10.24
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	15.44	5.94
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	19.83	9.15
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	15.54	9.93
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.88	6.99
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.01	10.36
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	19.69	9.53
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.89	8.70
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	7.56
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	17.29	8.82
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.87	8.15
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	16.24	7.82
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	16.77	8.02
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	16.09	10.57
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	17.85
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	21.86	12.46
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.72	11.35
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.69	7.04
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	9.08	11.95
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	11.31	8.65
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	15.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.63	9.97
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	13.50	12.18
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.36	6.91
Astrocyte - cerebellum, donor1	11500-119F6	10.93	14.62
Astrocyte - cerebellum, donor2	11580-120F5	9.76	8.90
Astrocyte - cerebellum, donor3	11661-122F5	7.76	5.03
Astrocyte - cerebral cortex, donor1	11235-116D2	13.59	8.37
Astrocyte - cerebral cortex, donor2	11316-117D2	11.32	11.65
Astrocyte - cerebral cortex, donor3	11392-118C6	12.53	8.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	30.05	17.66
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	32.32	26.18
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	35.28	24.81
Basophils, donor1	12241-129G9	55.18	14.12
Basophils, donor2	12242-129H1	70.72	23.81
Basophils, donor3	12243-129H2	41.75	13.23
Bronchial Epithelial Cell, donor1	11511-119G8	10.35	6.04
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	3.66
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	14.35
Bronchial Epithelial Cell, donor4	11453-119A4	9.41	8.79
Bronchial Epithelial Cell, donor5	11457-119A8	14.35	10.40
Bronchial Epithelial Cell, donor6	11461-119B3	13.59	8.75
Bronchial Epithelial Cell, donor7	11769-123I5	9.72	5.22
Burkitt's lymphoma cell line:DAUDI	10422-106C8	15.97	9.89
Burkitt's lymphoma cell line:RAJI	10476-106I8	13.28	8.85
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	12.15	14.71
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	20.68
CD14+ Monocytes, donor1	11224-116B9	35.50	10.14
CD14+ Monocytes, donor2	11305-117B9	33.41	8.17
CD14+ Monocytes, donor3	11381-118B4	33.59	10.76
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	32.55	21.23
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	33.74	15.92
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	23.67	17.42
CD14+ monocytes - mock treated, donor1	11863-125A9	45.82	17.49
CD14+ monocytes - mock treated, donor2	11873-125C1	57.93	19.01
CD14+ monocytes - mock treated, donor3	11883-125D2	45.72	18.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	45.87	12.05
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	50.79	10.21
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	67.44	11.16
CD14+ monocytes - treated with BCG, donor1	11860-125A6	39.94	5.48
CD14+ monocytes - treated with BCG, donor2	11870-125B7	56.98	8.72
CD14+ monocytes - treated with BCG, donor3	11880-125C8	62.46	9.79
CD14+ monocytes - treated with Candida, donor1	11868-125B5	53.62	6.56
CD14+ monocytes - treated with Candida, donor2	11878-125C6	77.62	11.62
CD14+ monocytes - treated with Candida, donor3	11888-125D7	89.86	9.98
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	46.56	12.35
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	53.08	10.38
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	57.05	16.45
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	39.35	4.12
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	57.46	5.20
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	50.63	7.42
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	32.28	8.07
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	44.31	10.99
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	39.98	12.20
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	44.64	4.41
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	56.71	4.93
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	64.05	6.58
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	48.13	6.80
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	50.18	7.81
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	69.41	12.07
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	33.17	2.87
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	80.20	8.11
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	75.86	5.34
CD14+CD16+ Monocytes, donor1	11789-124B7	24.85	12.21
CD14+CD16+ Monocytes, donor2	11801-124D1	21.48	10.39
CD14+CD16+ Monocytes, donor3	11912-125G4	21.88	9.31
CD14+CD16- Monocytes, donor1	11788-124B6	30.05	11.83
CD14+CD16- Monocytes, donor2	11799-124C8	26.72	8.21
CD14+CD16- Monocytes, donor3	11910-125G2	24.75	9.81
CD14-CD16+ Monocytes, donor1	11790-124B8	31.13	12.25
CD14-CD16+ Monocytes, donor2	11800-124C9	25.91	11.86
CD14-CD16+ Monocytes, donor3	11911-125G3	30.95	9.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	30.48	36.58
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	27.80	25.09
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	25.89	24.85
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	31.98	25.05
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	32.70	25.73
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	26.67	18.95
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	26.67	14.90
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	27.68	29.00
CD19+ B Cells, donor1	11544-120B5	57.53	15.62
CD19+ B Cells, donor2	11624-122B4	44.25	13.78
CD19+ B Cells, donor3	11705-123B4	49.47	13.13
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	51.72	7.27
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	46.74	4.39
CD34+ Progenitors, donor1	11545-120B6	13.05	8.03
CD34+ Progenitors, donor2	11625-122B5	34.27	12.36
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	14.65	12.02
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	15.78	15.11
CD4+ T Cells, donor1	11225-116C1	102.48	23.57
CD4+ T Cells, donor2	11306-117C1	75.32	25.11
CD4+ T Cells, donor3	11382-118B5	68.62	20.43
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	27.57	13.78
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	28.30	19.09
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	26.16	18.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	69.22	16.59
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	61.80	18.26
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	59.33	19.78
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	21.39	14.60
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	19.32	15.08
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	17.41	12.09
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	54.24	14.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	42.63	17.12
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	41.80	22.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	24.03	6.75
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	17.24	9.97
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	16.71	9.02
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	57.11	18.76
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	56.81	20.90
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	35.86	17.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	23.73	11.68
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	19.93	14.51
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	23.12	10.93
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	49.04	14.66
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	42.89	16.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	52.73	17.43
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	43.05	25.73
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	30.47	20.31
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	36.29	27.92
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	44.86	30.46
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	49.32	27.48
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	58.52	30.80
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	44.41	22.20
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	41.55	26.31
CD8+ T Cells, donor1	11226-116C2	92.65	26.52
CD8+ T Cells, donor2	11307-117C2	78.47	10.89
CD8+ T Cells, donor3	11383-118B6	92.16	22.47
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	10.09	10.55
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	10.30	8.15
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.30	7.39
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	18.01	11.41
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.24	9.84
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.00	9.78
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.04	5.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	8.16	3.95
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.50	6.57
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	10.57	5.74
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	10.75	8.13
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	9.06	7.19
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.94	3.50
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	9.56	4.10
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	3.73	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.44	7.20
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	12.66	9.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	13.20	8.25
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	10.46	7.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	13.84	8.30
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	10.26	6.41
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.03	4.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	5.91	7.49
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.08	7.56
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	15.26	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	20.28	10.49
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	23.04	7.01
Cardiac Myocyte, donor1	11525-119I4	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	6.42	7.91
Cardiac Myocyte, donor3	11686-122I3	10.21	9.37
Chondrocyte - de diff, donor1	11261-116G1	16.29	9.01
Chondrocyte - de diff, donor2	11338-117F6	14.57	14.57
Chondrocyte - de diff, donor3	11410-118E6	15.93	9.10
Chondrocyte - re diff, donor2	11339-117F7	25.07	16.11
Chondrocyte - re diff, donor3	11411-118E7	10.11	14.15
Ciliary Epithelial Cells, donor1	11242-116D9	14.92	11.71
Ciliary Epithelial Cells, donor2	11323-117D9	13.04	11.76
Ciliary Epithelial Cells, donor3	11399-118D4	11.86	11.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	24.48	10.36
Corneal Epithelial Cells, donor1	11526-119I5	7.69	4.39
Corneal Epithelial Cells, donor2	11606-120I4	14.79	10.24
Corneal Epithelial Cells, donor3	11687-122I4	12.27	5.88
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	24.27	8.92
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	23.02	10.72
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	10.35
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.76	11.01
Dendritic Cells - plasmacytoid, donor1	11228-116C4	55.35	22.55
Dendritic Cells - plasmacytoid, donor2	11309-117C4	45.70	23.50
Dendritic Cells - plasmacytoid, donor3	11385-118B8	51.78	30.97
Endothelial Cells - Aortic, donor0	11207-116A1	16.84	14.34
Endothelial Cells - Aortic, donor1	11263-116G3	11.15	6.45
Endothelial Cells - Aortic, donor2	11340-117F8	8.20	7.92
Endothelial Cells - Aortic, donor3	11412-118E8	11.40	9.83
Endothelial Cells - Artery, donor1	11264-116G4	9.31	6.40
Endothelial Cells - Artery, donor2	11341-117F9	9.65	7.06
Endothelial Cells - Artery, donor3	11413-118E9	15.08	10.34
Endothelial Cells - Lymphatic, donor1	11236-116D3	8.20	9.31
Endothelial Cells - Lymphatic, donor2	11317-117D3	12.17	9.74
Endothelial Cells - Lymphatic, donor3	11393-118C7	8.18	10.71
Endothelial Cells - Microvascular, donor1	11265-116G5	5.94	6.54
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	10.93
Endothelial Cells - Microvascular, donor3	11414-118F1	6.10	8.79
Endothelial Cells - Thoracic, donor1	11266-116G6	12.00	11.60
Endothelial Cells - Thoracic, donor2	11343-117G2	8.39	6.81
Endothelial Cells - Umbilical vein, donor1	11243-116E1	10.81	13.29
Endothelial Cells - Umbilical vein, donor2	11324-117E1	7.17	6.74
Endothelial Cells - Umbilical vein, donor3	11400-118D5	9.04	9.65
Endothelial Cells - Vein, donor1	11267-116G7	4.55	9.10
Endothelial Cells - Vein, donor2	11344-117G3	12.57	6.99
Endothelial Cells - Vein, donor3	11416-118F3	10.99	9.89
Eosinophils, donor1	12244-129H3	45.74	45.74
Eosinophils, donor2	12245-129H4	39.61	14.85
Eosinophils, donor3	12246-129H5	42.80	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	9.04	6.84
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	6.24
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.14	6.16
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.21	4.27
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	4.55	4.12
Fibroblast - Aortic Adventitial, donor1	11245-116E3	19.04	13.58
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	39.85	21.29
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.14	10.97
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	16.86	16.60
Fibroblast - Aortic Adventitial, donor3	11401-118D6	11.96	11.29
Fibroblast - Cardiac, donor1	11268-116G8	14.97	11.34
Fibroblast - Cardiac, donor2	11345-117G4	18.19	14.40
Fibroblast - Cardiac, donor3	11417-118F4	13.09	11.83
Fibroblast - Cardiac, donor4	11452-119A3	13.34	13.94
Fibroblast - Cardiac, donor5	11456-119A7	11.17	10.91
Fibroblast - Cardiac, donor6	11460-119B2	9.85	9.85
Fibroblast - Choroid Plexus, donor1	11492-119E7	15.54	13.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.63	7.77
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	10.25
Fibroblast - Conjunctival, donor1	11531-120A1	10.61	2.77
Fibroblast - Conjunctival, donor3	11692-122I9	12.72	9.50
Fibroblast - Dermal, donor1	11269-116G9	18.55	11.03
Fibroblast - Dermal, donor2	11346-117G5	30.19	14.62
Fibroblast - Dermal, donor3	11418-118F5	17.41	10.28
Fibroblast - Dermal, donor4	11450-119A1	10.51	8.70
Fibroblast - Dermal, donor5	11454-119A5	17.10	10.64
Fibroblast - Dermal, donor6	11458-119A9	12.67	12.99
Fibroblast - Gingival, donor1	11237-116D4	21.66	11.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	18.08	9.69
Fibroblast - Gingival, donor2	11318-117D4	14.76	6.19
Fibroblast - Gingival, donor3	11394-118C8	15.08	9.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	17.66	11.43
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	15.51	10.57
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	16.21	10.45
Fibroblast - Gingival, donor6 (control)	11922-125H5	13.12	8.38
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	9.53	5.29
Fibroblast - Gingival, donor7 (control)	11924-125H7	16.53	9.65
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.45	10.77
Fibroblast - Gingival, donor8 (control)	11926-125H9	15.58	9.87
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.99	7.19
Fibroblast - Lung, donor1	11270-116H1	19.03	6.80
Fibroblast - Lung, donor2	11347-117G6	8.95	5.97
Fibroblast - Lung, donor3	11419-118F6	14.77	9.71
Fibroblast - Lymphatic, donor1	11506-119G3	10.00	14.99
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	12.59
Fibroblast - Lymphatic, donor3	11667-122G2	3.92	5.60
Fibroblast - Mammary, donor1	11540-120B1	29.23	15.83
Fibroblast - Mammary, donor2	11620-122A9	19.97	11.98
Fibroblast - Mammary, donor3	11701-123A9	41.69	11.91
Fibroblast - Periodontal Ligament, donor1	11238-116D5	15.71	8.34
Fibroblast - Periodontal Ligament, donor2	11319-117D5	16.23	8.19
Fibroblast - Periodontal Ligament, donor3	11395-118C9	22.95	13.46
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.88	9.54
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	19.44	8.37
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	15.66	6.84
Fibroblast - Pulmonary Artery, donor1	11250-116E8	14.26	12.49
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	21.13	9.55
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	15.37	4.68
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.21	9.88
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	29.37	16.67
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	14.39	8.70
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	16.16	9.66
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	19.56	13.54
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	20.19	13.71
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	28.34	13.16
Fibroblast - skin normal, donor1	11553-120C5	17.23	8.37
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	28.27	12.23
Fibroblast - skin normal, donor2	11561-120D4	15.47	12.86
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.39	17.83
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	19.30	8.70
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	16.75	17.78
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.03	19.38
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.60	11.82
Fibroblast - skin walker warburg, donor1	11554-120C6	18.55	10.63
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	10.98	5.33
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	10.46	5.23
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.96	12.83
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	18.22	10.41
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	15.84	9.20
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	18.37	8.42
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	22.97	26.80
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	14.26	20.25
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	11.86	9.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	8.22	9.36
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	10.50	9.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	6.61	6.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	11.42	6.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	13.71	13.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	18.80	13.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	21.18	13.18
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	14.51	16.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	23.04	9.91
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	20.07	13.01
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	19.31	14.64
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	10.95	15.29
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	21.67	9.59
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	11.80	10.49
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	10.93	9.46
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	17.17	8.58
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	10.72	12.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	13.31	10.69
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	17.98	9.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	15.87	14.01
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	14.78	9.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	8.71	8.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	16.38	10.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	15.81	12.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	14.50	12.05
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	11.55	8.87
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	15.80	9.11
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	14.18	10.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	11.24	11.02
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	20.05	9.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	11.83	7.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	12.51	9.94
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	15.92	7.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	11.71	10.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	14.29	11.25
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	17.77	10.45
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	11.86	8.78
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	12.34	10.38
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	21.76	11.30
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	19.52	13.10
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.04	15.45
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	22.15	10.49
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	16.54	11.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	13.64	9.77
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	16.45	10.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	12.89	14.88
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	15.30	10.29
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	15.74	6.86
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	12.20	7.37
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	13.34	18.91
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	16.64	10.17
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	23.73	17.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	17.52	24.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	14.13	14.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	11.99	17.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	24.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	15.09	20.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	17.65	20.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	17.39	19.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	19.20	16.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	19.77	21.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	15.38	13.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	14.38	14.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	15.10	10.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	11.13	12.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	15.28	13.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	12.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	12.60	10.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	11.25	13.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	6.78	20.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	20.71	20.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.05	14.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	15.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	14.99	13.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	13.36	11.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	12.71	7.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	15.03	11.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	29.10	20.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	19.88	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	10.38	11.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	10.26	11.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	7.12	9.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	12.76	11.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.31	15.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	12.98	9.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	10.50	10.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	17.12	14.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	17.80	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	8.95	11.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	12.62	16.01
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	26.25	14.84
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.97	8.32
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	20.24	14.62
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	23.47	12.69
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	17.13	10.86
Hep-2 cells mock treated, biol_rep1	11898-125E8	47.81	28.55
Hep-2 cells mock treated, biol_rep2	11899-125E9	54.52	28.53
Hep-2 cells mock treated, biol_rep3	11900-125F1	43.68	30.49
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	51.48	32.79
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	45.13	27.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	50.16	28.85
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	46.58	24.41
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	40.83	24.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	40.37	24.99
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.16	8.95
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.19	3.03
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.58	11.64
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	5.81
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	14.69	14.51
Hepatocyte, donor1	11523-119I2	25.42	14.53
Hepatocyte, donor2	11603-120I1	18.31	2.15
Hepatocyte, donor3	11684-122I1	15.95	6.75
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	20.89	10.44
Intestinal epithelial cells (polarized), donor1	11246-116E4	37.75	16.43
Iris Pigment Epithelial Cells, donor1	11530-119I9	9.74	9.06
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	13.35
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	18.00	9.69
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	10.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	59.34
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	28.19	10.25
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	14.62	21.12
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	15.01
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	18.53
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	26.61	15.52
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	27.08	11.97
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	32.48	9.28
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	40.70	8.40
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	35.04	7.33
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	25.61	8.82
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	36.17	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	19.39	15.70
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	25.96	7.55
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	16.33	5.44
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	29.48
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	17.22	10.76
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	27.95	7.62
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	26.78	6.38
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	16.40
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	29.99	9.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	27.78	10.19
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	26.34	7.02
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	9.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	33.38	6.95
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	24.34	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.08	5.23
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	13.94
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	24.54	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	15.24
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	16.57	7.36
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	9.08
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	12.42
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	22.20	4.23
Keratinocyte - epidermal, donor1	11272-116H3	21.54	8.89
Keratinocyte - epidermal, donor2	11349-117G8	15.23	10.54
Keratinocyte - epidermal, donor3	11421-118F8	16.09	8.05
Keratinocyte - oral, donor1	11251-116E9	21.34	10.67
Keratocytes, donor1	11527-119I6	15.82	7.56
Keratocytes, donor2	11607-120I5	4.69	5.86
Keratocytes, donor3	11688-122I5	12.05	6.32
Krukenberg tumor cell line:HSKTC	10687-109F3	24.18	4.40
Lens Epithelial Cells, donor1	11529-119I8	14.02	7.55
Lens Epithelial Cells, donor2	11609-120I7	12.57	11.88
Lens Epithelial Cells, donor3	11690-122I7	16.65	13.72
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	7.59	10.43
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.42	7.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	7.24	10.39
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	7.53
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.67	7.25
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.68	9.60
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	7.39	5.34
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.09	7.08
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.30	7.74
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	6.33	7.91
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.53	11.25
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.11	7.96
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	7.67	10.45
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.87	10.26
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.52	6.87
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.31	9.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.30	6.86
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.88	9.15
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.90	7.90
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.15	9.08
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	11.20	11.70
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.76	8.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.35	11.58
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.78	9.99
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.67	10.89
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	12.14	10.68
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.81	7.07
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.19	10.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.59	8.84
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	6.15	8.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.69	7.75
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.27	10.25
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.31	8.92
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.55	8.14
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	10.13	8.89
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.05	7.42
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.75	8.68
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.22	8.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.84	8.68
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.24	8.18
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	10.18
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.38	9.49
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.80	11.82
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.15	11.76
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.94	8.95
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	9.41	12.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.40	8.96
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	10.74	9.85
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	30.69	11.51
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	21.52	19.30
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	29.20	17.77
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	21.10	21.80
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	20.55	18.68
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	29.37	15.46
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	15.46	9.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	24.88	20.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	26.47	18.32
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	26.56	16.21
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	31.43	21.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	28.76	14.89
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	25.41	11.64
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.32	10.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	31.07	15.79
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	26.95	17.88
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	29.66	14.93
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	26.38	15.95
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	20.39	26.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	27.07	20.20
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	27.47	15.13
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	25.76	11.33
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	27.87	15.97
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	20.93	20.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	19.92	20.47
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	37.82	23.68
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	27.29	18.44
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	26.48	16.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	30.32	18.80
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	20.95	19.25
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	27.90
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	29.82	19.88
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	30.16	22.98
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	19.42	19.42
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	28.24	18.21
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	20.68	14.65
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	19.69	11.13
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	26.32	14.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	27.75	17.50
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	19.91	21.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	24.75	14.78
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	25.23	16.64
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	19.53	18.18
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.93	17.78
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	29.07	18.61
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	14.81	16.92
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	24.81	21.21
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	33.44	23.99
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	29.13	19.93
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	31.57	16.28
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	29.17	16.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	20.62	17.60
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	27.04	17.12
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	29.26	18.93
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	28.50	23.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	37.54	23.46
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	24.41	12.53
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	33.73	19.20
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	34.13	24.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	31.31	17.89
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	26.94	16.78
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	32.40	15.81
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	27.34	19.75
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	27.40	17.30
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	22.66	18.68
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	16.41	20.66
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	18.68	13.83
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	34.96	21.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	26.85	14.46
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	27.21	18.74
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	31.37	19.01
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	31.99	19.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	26.43	17.24
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	45.77	20.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	37.49	24.76
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	26.67	19.29
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	28.29	17.47
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	24.27	25.06
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	21.71	17.54
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	27.41	25.09
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	30.78	22.75
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	22.99	21.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	32.73	19.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	32.12	19.27
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	27.56	15.11
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	26.21	21.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	29.14	14.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	25.17	17.51
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	30.29	23.61
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	37.95	21.58
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	24.53	21.88
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	22.86
Macrophage - monocyte derived, donor1	11232-116C8	26.44	11.17
Macrophage - monocyte derived, donor2	11313-117C8	24.41	11.56
Macrophage - monocyte derived, donor3	11389-118C3	25.82	11.01
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	16.46	14.87
Mallassez-derived cells, donor2	11929-125I3	19.65	10.30
Mallassez-derived cells, donor3	11930-125I4	19.32	13.06
Mammary Epithelial Cell, donor1	11273-116H4	24.51	13.35
Mammary Epithelial Cell, donor2	11350-117G9	19.11	10.71
Mammary Epithelial Cell, donor3	11422-118F9	17.21	8.73
Mast cell - stimulated, donor1	11487-119E2	102.37	115.25
Mast cell, donor1	11563-120D6	19.14	22.60
Mast cell, donor2	11565-120D8	33.88	24.67
Mast cell, donor3	11566-120D9	29.72	16.88
Mast cell, donor4	11567-120E1	27.48	18.62
Mast cell, expanded and stimulated, donor5	11940-126A5	23.29	19.85
Mast cell, expanded and stimulated, donor8	11942-126A7	23.35	19.85
Mast cell, expanded, donor5	11939-126A4	18.70	14.57
Mast cell, expanded, donor8	11941-126A6	19.41	25.77
Melanocyte - dark, donor1	11502-119F8	7.16	10.85
Melanocyte - dark, donor2	11582-120F7	7.27	7.61
Melanocyte - dark, donor3	11663-122F7	28.11	13.40
Melanocyte - light, donor1	11274-116H5	25.86	9.17
Melanocyte - light, donor2	11351-117H1	13.65	10.92
Melanocyte - light, donor3	11423-118G1	15.61	6.94
Melanocyte, donor1 (MC+1)	12641-134G4	30.20	8.33
Melanocyte, donor2 (MC+2)	12739-135I3	23.94	9.68
Melanocyte, donor3 (MC+3)	12837-137B2	14.20	14.46
Meningeal Cells, donor1	11493-119E8	18.61	17.12
Meningeal Cells, donor2	11573-120E7	14.97	14.52
Meningeal Cells, donor3	11654-122E7	18.42	11.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	14.54	8.27
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	26.37	10.47
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	3.94
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	18.66	9.33
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	17.58	12.07
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	11.56	9.55
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	12.31	11.65
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.07	10.23
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.46	7.77
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	18.01	12.05
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.83	4.09
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	11.97	7.37
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.31	5.34
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.73	8.33
Mesenchymal stem cells - adipose, donor0	11217-116B2	23.04	14.89
Mesenchymal stem cells - hepatic, donor0	11218-116B3	18.76	7.51
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.79	11.61
Mesothelial Cells, donor1	11247-116E5	18.83	10.34
Mesothelial Cells, donor2	12156-128G5	30.03	11.01
Mesothelial Cells, donor3	11402-118D7	15.10	7.44
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	21.61	4.05
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	28.81	14.04
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	27.38	13.25
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	17.67	9.61
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	22.20	7.68
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	20.52	9.51
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	21.88	8.84
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	24.79	9.14
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	19.01	9.11
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	20.35	6.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	28.88	11.02
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	30.35	9.34
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	16.57	4.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	18.78	4.47
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	30.86	6.27
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	24.72	6.89
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.29	2.76
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	23.95	3.68
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.93	6.52
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	11.41	3.06
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	27.25	5.58
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	15.12	5.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	16.43	4.60
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.13	3.04
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	14.13	4.89
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	14.41	5.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	22.59	5.77
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	23.21	8.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	21.52	11.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	6.12
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	23.65	8.76
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	3.31
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	4.48
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.07	12.15
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	14.61	5.57
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	8.84
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	20.17	9.57
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.75	10.50
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.81	2.84
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	23.29	10.10
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.88	8.73
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.07	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	18.70	8.45
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	27.55	16.70
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	14.44
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.01	10.16
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	18.21	13.09
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	18.10	6.22
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	19.95	11.40
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	23.59	10.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	7.62	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.61	8.54
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	26.34	15.86
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	17.23	5.37
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	18.16	11.47
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.77	13.49
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.34	5.69
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.16	11.65
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	28.27	14.01
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	6.52	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.35	10.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	24.51	12.97
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	24.32	5.77
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	17.87	10.42
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	24.31	6.90
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	23.14	4.21
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	28.47	8.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	17.70	6.52
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	31.92	14.27
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	26.37	9.32
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	24.09	8.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	17.68	4.42
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	23.08	6.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	23.33	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.21	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	21.21	6.06
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.01	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	23.15	5.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	15.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	85.65	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	9.79
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	14.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	25.10
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	18.31	19.39
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.72	9.41
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	2.67	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	3.76	2.92
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	11.60	7.42
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	7.98	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.04	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	42.27	23.89
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.37	3.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	9.07	6.97
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	6.76	4.86
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	7.36	6.52
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	5.96	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	9.47	4.87
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.35	3.63
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.37	2.61
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	12.39	10.94
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	3.18	5.30
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	21.00	5.91
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.83	3.42
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	12.88	9.17
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	5.63	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.98	4.60
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	6.11	5.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	18.62	6.55
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	42.98	15.17
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	12.48	11.36
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.08	3.81
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.31	3.80
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.87	5.15
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	3.33	4.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	10.37	5.86
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.56	6.35
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	4.64	6.50
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	10.97	7.95
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.89	3.91
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	3.92	2.61
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	16.28	9.05
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	8.82	6.17
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.99	5.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.95	5.95
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.21	3.83
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	10.59	9.38
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	19.01	9.06
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.71	3.39
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	15.33
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.15	4.88
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	8.50	3.78
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.15	3.03
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	3.16	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	29.47	5.67
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	15.17
Myoblast, donor1	11241-116D8	35.90	17.27
Myoblast, donor2	11322-117D8	20.52	14.38
Myoblast, donor3	11398-118D3	23.71	14.63
NK T cell leukemia cell line:KHYG-1	10777-110G3	23.06	8.90
Natural Killer Cells, donor1	11230-116C6	77.49	19.07
Natural Killer Cells, donor2	11311-117C6	74.79	17.79
Natural Killer Cells, donor3	11387-118C1	75.28	12.88
Neural stem cells, donor1	11275-116H6	21.05	14.15
Neural stem cells, donor2	11352-117H2	26.96	13.48
Neurons, donor1	11494-119E9	30.72	14.79
Neurons, donor2	11574-120E8	22.90	14.31
Neurons, donor3	11655-122E8	28.78	15.62
Neutrophils, donor1	11233-116C9	38.05	6.50
Neutrophils, donor2	11314-117C9	34.79	5.80
Neutrophils, donor3	11390-118C4	49.48	11.00
Nucleus Pulposus Cell, donor1	11252-116F1	16.86	12.47
Nucleus Pulposus Cell, donor2	11409-118E5	8.14	9.44
Nucleus Pulposus Cell, donor3	11462-119B4	10.63	7.42
Olfactory epithelial cells, donor1	11933-125I7	10.74	8.67
Olfactory epithelial cells, donor2	11934-125I8	16.94	9.55
Olfactory epithelial cells, donor3	11935-125I9	13.05	7.72
Olfactory epithelial cells, donor4	11936-126A1	14.61	7.40
Oligodendrocyte - precursors, donor1	11496-119F2	16.25	11.43
Osteoblast - differentiated, donor1	11276-116H7	24.03	14.04
Osteoblast - differentiated, donor2	11353-117H3	24.01	8.00
Osteoblast - differentiated, donor3	11425-118G3	6.83	9.31
Osteoblast, donor1	11277-116H8	27.36	17.20
Osteoblast, donor2	11354-117H4	13.34	9.13
Osteoblast, donor3	11426-118G4	24.17	12.80
Pancreatic stromal cells, donor1	11249-116E7	17.35	10.78
Pericytes, donor1	11491-119E6	5.12	5.90
Pericytes, donor2	11571-120E5	8.60	9.28
Pericytes, donor3	11652-122E5	15.46	10.58
Perineurial Cells, donor1	11499-119F5	13.22	9.72
Perineurial Cells, donor2	11579-120F4	11.41	12.61
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	61.84	15.62
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	35.75	10.28
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	35.72	15.92
Placental Epithelial Cells, donor1	11278-116H9	61.94	7.89
Placental Epithelial Cells, donor2	11355-117H5	14.42	9.98
Placental Epithelial Cells, donor3	11427-118G5	15.51	11.78
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	5.38	4.43
Preadipocyte - breast, donor1	11467-119B9	24.57	11.82
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	32.76	17.62
Preadipocyte - breast, donor2	11328-117E5	24.54	14.41
Preadipocyte - omental, donor1	11468-119C1	25.47	10.87
Preadipocyte - omental, donor2	11329-117E6	17.02	13.97
Preadipocyte - omental, donor3	11403-118D8	23.35	14.75
Preadipocyte - perirenal, donor1	11469-119C2	17.72	11.81
Preadipocyte - subcutaneous, donor1	11279-116I1	31.33	13.51
Preadipocyte - subcutaneous, donor2	11356-117H6	19.48	13.81
Preadipocyte - subcutaneous, donor3	11428-118G6	18.22	11.41
Preadipocyte - visceral, donor1	11280-116I2	20.68	11.18
Preadipocyte - visceral, donor2	11357-117H7	26.23	12.42
Preadipocyte - visceral, donor3	11429-118G7	10.34	8.46
Prostate Epithelial Cells (polarized), donor1	11253-116F2	41.03	15.54
Prostate Epithelial Cells, donor2	11331-117E8	14.22	6.23
Prostate Epithelial Cells, donor3	11404-118D9	21.00	7.16
Prostate Stromal Cells, donor1	11254-116F3	21.87	13.78
Prostate Stromal Cells, donor2	11332-117E9	21.87	13.09
Prostate Stromal Cells, donor3	11405-118E1	18.56	10.84
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.49	9.85
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.43	8.04
Renal Epithelial Cells, donor1	11517-119H5	8.62	7.61
Renal Epithelial Cells, donor2	11597-120H4	8.54	7.82
Renal Epithelial Cells, donor3	11678-122H4	17.26	10.69
Renal Glomerular Endothelial Cells, donor1	11514-119H2	5.45	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	6.60	6.74
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.99	10.21
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	2.66
Renal Mesangial Cells, donor1	11518-119H6	9.02	8.80
Renal Mesangial Cells, donor2	11598-120H5	6.27	6.27
Renal Mesangial Cells, donor3	11679-122H5	7.21	5.27
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	14.49	11.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.43	3.37
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	9.84	9.26
Retinal Pigment Epithelial Cells, donor0	11215-116A9	15.56	9.59
Retinal Pigment Epithelial Cells, donor1	11528-119I7	13.93	15.06
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1.03	4.12
Retinal Pigment Epithelial Cells, donor3	11689-122I6	20.07	11.29
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	18.84	10.29
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	13.40	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	22.01	11.56
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	19.72	9.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	10.14	9.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	11.12	8.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	15.17	10.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	22.33	16.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	13.64	6.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	18.95	11.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	9.72	6.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	13.61	8.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	13.98	9.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	10.47	8.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	13.63	7.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	10.84	8.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	8.99	6.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	10.06	8.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	18.79	10.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	7.96	6.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	13.53	7.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	15.09	9.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	10.79	6.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	16.26	7.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	14.70	9.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	7.66	8.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	12.63	5.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	18.00	11.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	12.03	15.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	15.28	6.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	18.01	9.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	11.82	7.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	16.81	6.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	12.95	10.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	12.25	11.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	12.94	6.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	11.76	11.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	11.69	9.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	11.39	7.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	13.30	9.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	9.03	8.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	14.20	7.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	11.73	7.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	7.88	8.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	12.86	5.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	10.88	9.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	9.04	6.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	13.97	7.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	11.79	7.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	12.85	6.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	19.21	8.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	15.21	9.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	9.04	9.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	14.93	9.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	14.08	8.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	16.77	11.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	16.86	8.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	13.82	7.81
Schwann Cells, donor1	11498-119F4	6.58	7.52
Schwann Cells, donor2	11578-120F3	3.40	13.61
Schwann Cells, donor3	11659-122F3	16.65	11.17
Sebocyte, donor1	11220-116B5	29.03	16.98
Sebocyte, donor2	11301-117B5	20.68	10.57
Sebocyte, donor3	11378-118B1	26.38	12.78
Sertoli Cells, donor1	11255-116F4	21.54	6.63
Sertoli Cells, donor2	11333-117F1	11.30	5.65
Skeletal Muscle Cells, donor1	11281-116I3	16.45	8.62
Skeletal Muscle Cells, donor2	11358-117H8	40.48	18.79
Skeletal Muscle Cells, donor3	11430-118G8	14.21	6.69
Skeletal Muscle Cells, donor4	11451-119A2	13.20	11.31
Skeletal Muscle Cells, donor5	11455-119A6	13.53	10.26
Skeletal Muscle Cells, donor6	11459-119B1	18.16	12.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	20.54	13.73
Skeletal Muscle Satellite Cells, donor2	11321-117D7	16.27	12.27
Skeletal Muscle Satellite Cells, donor3	11397-118D2	19.05	15.77
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.77	9.77
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	15.20	10.13
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	12.66	10.32
Skin - palm, donor1	10286-104F7	10.74	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.05	2.59
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	10.63	14.72
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.32	2.47
Small Airway Epithelial Cells, donor1	11256-116F5	17.24	7.78
Small Airway Epithelial Cells, donor2	11334-117F2	14.49	8.30
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	28.12	13.32
Small Airway Epithelial Cells, donor3	11406-118E2	18.51	6.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.42	7.41
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	22.23	13.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	20.57	18.81
Smooth Muscle Cells - Aortic, donor1	11283-116I5	13.48	12.60
Smooth Muscle Cells - Aortic, donor2	11360-117I1	25.20	18.51
Smooth Muscle Cells - Aortic, donor3	11432-118H1	26.27	19.31
Smooth Muscle Cells - Bladder, donor1	11519-119H7	6.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	21.56	12.91
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.74	13.96
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	16.52	16.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	18.56	15.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	18.90	12.99
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	17.23	11.25
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	13.01	7.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.00	7.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.15	13.64
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.40	9.54
Smooth Muscle Cells - Colonic, donor1	11239-116D6	28.90	11.50
Smooth Muscle Cells - Colonic, donor2	11320-117D6	18.94	12.05
Smooth Muscle Cells - Colonic, donor3	11396-118D1	20.89	12.49
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	30.47	19.64
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	21.56	15.09
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.85	13.15
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	8.53	6.83
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	13.35	9.58
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	21.44	9.76
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	17.52	13.65
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	13.89	12.68
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	22.25	12.19
Smooth Muscle Cells - Prostate, donor1	11257-116F6	16.51	11.98
Smooth Muscle Cells - Prostate, donor2	11335-117F3	19.66	11.52
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.28	9.39
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	20.96	14.62
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.00	12.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	7.75	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	18.60	11.63
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	19.19	10.10
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	18.80	13.48
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.68	7.37
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	18.24	16.24
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	9.34	7.94
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	27.78	12.23
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	24.22	9.43
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.22	8.27
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.28	10.48
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	16.84	9.38
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.71	4.29
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	22.51	12.23
Smooth Muscle Cells - Uterine, donor1	11258-116F7	24.53	11.71
Smooth Muscle Cells - Uterine, donor3	11466-119B8	12.87	5.56
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	9.91	5.44
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	20.10	7.67
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	27.15	14.51
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.92	9.34
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	30.66	11.36
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	14.97	7.88
Smooth muscle cells - airway, control, donor1	11966-126D4	11.17	6.86
Smooth muscle cells - airway, control, donor2	11967-126D5	11.98	4.39
Smooth muscle cells - airway, control, donor3	11968-126D6	11.70	5.85
Smooth muscle cells - airway, control, donor4	11969-126D7	21.54	5.96
Synoviocyte, donor1	11291-117A4	21.71	6.73
Synoviocyte, donor2	11368-117I9	10.73	8.72
Synoviocyte, donor3	11440-118H9	6.93	7.37
Trabecular Meshwork Cells, donor1	11532-120A2	8.93	9.29
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	5.09	5.09
Tracheal Epithelial Cells, donor1	11292-117A5	21.08	11.97
Tracheal Epithelial Cells, donor2	11369-118A1	13.14	8.89
Tracheal Epithelial Cells, donor3	11441-118I1	14.32	12.60
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	20.91	9.23
Urethra, donor2	10319-105A4	10.79	1.80
Urothelial Cells, donor1	11520-119H8	9.56	6.11
Urothelial Cells, donor2	11600-120H7	8.81	5.61
Urothelial Cells, donor3	11681-122H7	7.79	4.35
Urothelial cells, donor0	11216-116B1	10.25	10.03
Whole blood (ribopure), donor090309, donation1	12179-129A1	40.04	12.46
Whole blood (ribopure), donor090309, donation2	12180-129A2	30.02	21.44
Whole blood (ribopure), donor090309, donation3	12181-129A3	16.43	6.85
Whole blood (ribopure), donor090325, donation1	12176-128I7	26.86	15.84
Whole blood (ribopure), donor090325, donation2	12177-128I8	27.89	15.11
Whole blood (ribopure), donor090612, donation1	12182-129A4	38.53	9.37
Whole blood (ribopure), donor090612, donation2	12183-129A5	38.55	21.11
Whole blood (ribopure), donor090612, donation3	12184-129A6	19.17	13.69
Wilms' tumor cell line:G-401	10809-111A8	9.62	11.97
Wilms' tumor cell line:HFWT	10597-108E3	6.16	6.16
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	42.18	9.22
achilles tendon, donor2	10292-104G4	14.47	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	16.32	11.73
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	24.38	14.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	31.93	11.51
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	18.23	18.23
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	14.62	19.11
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	19.46	13.96
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	15.52	12.25
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	14.98	13.22
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	15.11	11.84
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	27.18	12.43
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	27.23	19.69
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	15.34	12.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	17.35	15.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	14.90	13.74
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	38.11	20.45
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	8.23	4.11
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	10.13	4.60
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	24.32	17.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	26.99	14.86
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	30.57	16.37
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	19.16	12.70
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	26.02	16.68
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	5.57	7.43
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	19.96	15.44
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	17.45	20.93
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	5.62	26.24
adenocarcinoma cell line:IM95m	10796-110I4	15.78	6.12
adipose tissue, adult, pool1	10010-101C1	16.75	9.31
adipose, donor1	10184-103D4	18.77	9.38
adipose, donor2	10185-103D5	6.08	6.08
adipose, donor3	10186-103D6	8.44	7.35
adipose, donor4	10187-103D7	11.27	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	10.26	7.10
adrenal gland, adult, pool1	10081-102A9	7.28	14.55
adult T-cell leukemia cell line:ATN-1	10421-106C7	41.22	15.21
alveolar cell carcinoma cell line:SW 1573	10708-109H6	31.80	12.51
amniotic membrane cells, donor1	12235-129G3	38.26	9.74
amniotic membrane cells, donor2	12236-129G4	26.71	10.48
amniotic membrane cells, donor3	12237-129G5	30.64	6.48
amygdala - adult, donor10196	10167-103B5	16.60	9.49
amygdala, adult, donor10252	10151-102I7	32.65	14.80
amygdala, newborn, donor10223	10360-105E9	29.37	4.84
anaplastic carcinoma cell line:8305C	10428-106D5	35.27	14.26
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	21.84	8.82
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	16.37	8.68
aorta, adult, pool1	10052-101G7	12.36	6.67
appendix, adult	10189-103D9	15.14	11.64
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	13.76	20.64
artery, adult	10190-103E1	13.59	5.43
astrocytoma cell line:TM-31	10425-106D2	31.00	14.20
b cell line:RPMI1788	10427-106D4	20.67	17.84
basal cell carcinoma cell line:TE 354.T	10702-109G9	24.69	8.88
bile duct carcinoma cell line:HuCCT1	10432-106D9	26.30	10.42
bile duct carcinoma cell line:TFK-1	10496-107C1	77.16	18.75
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	16.78	8.95
bladder, adult, pool1	10011-101C2	15.64	9.67
blood, adult, pool1	10053-101G8	17.72	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	23.12	3.43
bone marrow, adult	10192-103E3	12.82	14.17
brain, adult, donor1	10084-102B3	18.45	8.20
brain, adult, pool1	10012-101C3	23.50	13.14
brain, fetal, pool1	10085-102B4	8.01	10.69
breast carcinoma cell line:MCF7	10482-107A5	44.93	25.11
breast carcinoma cell line:MDA-MB-453	10419-106C5	20.60	7.86
breast, adult, donor1	10080-102A8	8.21	5.05
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	28.46	20.96
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	19.48	10.51
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	29.47	11.05
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	18.16	10.89
carcinoid cell line:NCI-H1770	10703-109H1	8.46	7.05
carcinoid cell line:NCI-H727	10735-110B6	18.05	4.81
carcinoid cell line:SK-PN-DW	10719-109I8	13.94	8.24
carcinosarcoma cell line:JHUCS-1	10642-109A3	23.96	13.58
caudate nucleus - adult, donor10196	10177-103C6	14.97	13.82
caudate nucleus, adult, donor10252	10164-103B2	21.25	15.23
caudate nucleus, adult, donor10258	10379-105H1	11.46	5.35
caudate nucleus, newborn, donor10223	10354-105E3	28.93	6.96
cerebellum - adult, donor10196	10173-103C2	32.05	14.57
cerebellum, adult, donor10252	10166-103B4	47.40	24.13
cerebellum, adult, pool1	10083-102B2	15.52	11.04
cerebellum, newborn, donor10223	10357-105E6	29.06	14.95
cerebral meninges, adult	10188-103D8	16.89	8.57
cerebrospinal fluid, donor2	10294-104G6	6.58	4.39
cervical cancer cell line:D98-AH2	10552-107I3	137.60	52.19
cervical cancer cell line:ME-180	10553-107I4	86.67	19.72
cervix, adult, pool1	10013-101C4	14.49	9.13
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	38.04	17.56
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	5.23
choriocarcinoma cell line:BeWo	10423-106C9	34.18	14.79
choriocarcinoma cell line:SCH	10785-110H2	12.44	13.18
choriocarcinoma cell line:T3M-3	10618-108G6	17.55	11.62
chorionic membrane cells, donor1	12238-129G6	27.92	6.55
chorionic membrane cells, donor2	12239-129G7	24.86	14.02
chorionic membrane cells, donor3	12240-129G8	40.66	12.64
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	17.17	8.08
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	12.10	11.33
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	12.46	11.83
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	29.79	11.56
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	27.33	13.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	32.98	12.83
chronic myelogenous leukemia cell line:K562	10454-106G4	25.32	17.08
chronic myelogenous leukemia cell line:KU812	10409-106B4	9.90	13.55
clear cell carcinoma cell line:JHOC-5	10638-108I8	22.17	17.14
clear cell carcinoma cell line:TEN	10636-108I6	24.46	3.64
colon carcinoma cell line:CACO-2	10513-107D9	40.09	18.49
colon carcinoma cell line:COLO-320	10420-106C6	18.62	11.02
colon, adult, donor1	10082-102B1	13.09	10.71
colon, adult, pool1	10014-101C5	19.86	9.05
colon, fetal, donor1	10070-101I7	14.83	8.03
common myeloid progenitor CMP, donor1	12130-128D6	4.58	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	33.57	15.30
cord blood derived cell line:COBL-a 24h infection	10453-106G3	24.00	14.49
cord blood derived cell line:COBL-a untreated	10449-106F8	20.73	16.08
corpus callosum, adult, pool1	10042-101F6	30.40	9.95
cruciate ligament, donor2	10295-104G7	10.54	4.86
diaphragm, fetal, donor1	10069-101I6	10.43	4.82
diencephalon, adult	10193-103E4	20.16	12.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	13.32	10.33
ductal cell carcinoma cell line:KLM-1	10438-106E6	36.41	14.36
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	19.02	6.50
ductus deferens, adult	10196-103E7	12.96	7.48
duodenum, fetal, donor1, tech_rep1	10071-101I8	10.08	10.08
duodenum, fetal, donor1, tech_rep2	10071-101I8	20.60	13.98
dura mater, adult, donor1	10041-101F5	19.41	9.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	125.69	25.76
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	32.96	16.48
embryonic pancreas cell line:1B2C6	10604-108F1	27.13	8.63
embryonic pancreas cell line:1C3D3	10605-108F2	19.07	4.24
embryonic pancreas cell line:1C3IKEI	10606-108F3	30.26	7.10
embryonic pancreas cell line:2C6	10603-108E9	40.72	5.25
endometrial carcinoma cell line:OMC-2	10497-107C2	24.80	14.41
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	32.44	9.61
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	17.37	10.61
epidermoid carcinoma cell line:A431	10426-106D3	16.45	4.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	39.04	11.44
epididymis, adult	10197-103E8	16.33	5.23
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	11.00	9.93
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	9.83	7.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	62.64	38.40
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	74.41	42.22
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	70.58	38.31
esophagus, adult, pool1	10015-101C6	14.33	7.01
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	15.28	12.27
eye - muscle inferior rectus, donor1	10272-104E2	19.32	4.83
eye - muscle lateral, donor2	10298-104H1	8.42	0.00
eye - muscle medial, donor2	10299-104H2	14.88	2.98
eye - muscle superior, donor2	10297-104G9	8.03	4.59
eye - vitreous humor, donor1	10268-104D7	5.83	4.37
eye, fetal, donor1	10054-101G9	15.00	9.41
fibrosarcoma cell line:HT-1080	10758-110E2	26.54	15.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	20.66	11.16
frontal lobe, adult, pool1	10040-101F4	28.99	15.11
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	16.51	14.71
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	48.55	17.92
gall bladder, adult	10198-103E9	15.93	8.69
gamma delta positive T cells, donor1	11937-126A2	24.16	11.81
gamma delta positive T cells, donor2	11938-126A3	35.11	14.94
gastric adenocarcinoma cell line:MKN1	10614-108G2	53.23	25.98
gastric adenocarcinoma cell line:MKN45	10612-108F9	64.21	23.02
gastric cancer cell line:AZ521	10549-107H9	20.00	16.07
gastric cancer cell line:GSS	10560-108A2	17.39	10.98
gastrointestinal carcinoma cell line:ECC12	10615-108G3	42.72	22.16
giant cell carcinoma cell line:LU65	10487-107B1	80.32	22.60
giant cell carcinoma cell line:Lu99B	10433-106E1	44.23	15.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	13.47	6.73
glioblastoma cell line:A172, tech_rep1	10444-106F3	19.95	8.02
glioblastoma cell line:A172, tech_rep2	10444-106F3	20.08	8.01
glioblastoma cell line:T98G	10485-107A8	20.97	6.51
glioma cell line:GI-1	10413-106B8	22.84	17.87
globus pallidus - adult, donor10196	10175-103C4	28.43	12.39
globus pallidus, adult, donor10252	10161-103A8	52.24	11.47
globus pallidus, adult, donor10258	10367-105F7	15.06	2.74
globus pallidus, newborn, donor10223	10364-105F4	25.58	5.33
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	19.58
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	15.68
granulosa cell tumor cell line:KGN	10624-108H3	10.56	5.76
hIPS +CCl2, biol_rep1	14383-156B9	7.80	10.56
hIPS +CCl2, biol_rep2	14384-156C1	6.86	15.55
hIPS +CCl2, biol_rep3	14385-156C2	7.09	5.80
hIPS, biol_rep1	14380-156B6	8.62	24.43
hIPS, biol_rep2	14381-156B7	13.72	8.92
hIPS, biol_rep3	14382-156B8	9.93	4.41
hairy cell leukemia cell line:Mo	10712-109I1	20.40	15.52
heart - mitral valve, adult	10205-103F7	13.75	10.16
heart - pulmonic valve, adult	10206-103F8	28.24	13.60
heart - tricuspid valve, adult	10207-103F9	11.66	10.82
heart, adult, diseased post-infarction, donor1	10050-101G5	33.67	12.04
heart, adult, diseased, donor1	10051-101G6	62.17	22.14
heart, adult, pool1	10016-101C7	41.86	14.95
heart, fetal, pool1	10046-101G1	52.67	12.83
hepatic mesenchymal tumor cell line:LI90	10778-110G4	11.11	4.94
hepatoblastoma cell line:HuH-6	10633-108I3	28.54	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	24.86	23.87
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	24.27	29.25
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	24.66	26.58
hepatoma cell line:Li-7	10484-107A7	61.06	17.91
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	13.87	8.14
hippocampus - adult, donor10196	10169-103B7	18.93	11.36
hippocampus, adult, donor10252	10153-102I9	32.66	8.37
hippocampus, adult, donor10258	10374-105G5	19.42	7.97
hippocampus, newborn, donor10223	10363-105F3	19.03	8.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	27.47	21.36
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	14.53	12.17
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	15.23	11.43
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	5.64	7.33
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	8.00	10.33
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	12.53	7.97
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	17.81	12.85
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	12.28	9.05
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	9.59	10.43
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	18.00	17.52
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	13.50	11.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	12.79
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	9.55	11.89
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	10.32	11.30
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	14.84	13.09
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	12.22	7.64
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	7.85	6.98
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	11.99	11.49
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.43	7.54
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	12.28	8.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	12.53	5.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	10.78	8.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	11.61	10.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.66	7.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	13.67	12.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	13.98	13.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	24.50	18.78
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	12.67	7.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	5.38	11.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	14.83	9.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	9.83	5.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	7.31	9.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	13.34	8.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	9.97	12.78
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	7.57	12.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	10.75	9.75
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	12.56	14.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	12.48	11.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	16.59	15.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	9.47	7.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	84.58	42.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	16.88	14.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	12.04	7.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	10.86	9.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	13.88	9.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	4.77	13.13
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	13.00	12.59
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	10.24	10.24
immature langerhans cells, donor1	11904-125F5	36.81	13.32
immature langerhans cells, donor2	11905-125F6	20.60	11.09
insula, adult, pool1	10039-101F3	33.59	13.25
keratoacanthoma cell line:HKA-1	10791-110H8	23.09	14.96
kidney, adult, pool1	10017-101C8	22.73	7.31
kidney, fetal, pool1	10045-101F9	15.35	7.99
large cell lung carcinoma cell line:IA-LM	10509-107D5	33.52	37.78
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.32	8.43
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	40.55	8.07
left atrium, adult, donor1	10079-102A7	10.90	7.08
left ventricle, adult, donor1	10078-102A6	31.86	10.11
leiomyoblastoma cell line:G-402	10721-110A1	7.39	7.66
leiomyoma cell line:10964C	10569-108B2	22.99	13.29
leiomyoma cell line:15242A	10570-108B3	21.20	15.76
leiomyoma cell line:15425	10571-108B4	17.24	13.84
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	25.40
lens epithelial cell line:SRA 01/04	10647-109A8	13.59	7.32
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	13.58	15.11
liposarcoma cell line:KMLS-1	10782-110G8	13.90	6.56
liposarcoma cell line:SW 872	10726-110A6	22.78	10.84
liver, adult, pool1	10018-101C9	15.88	10.53
liver, fetal, pool1	10086-102B5	2.82	5.64
locus coeruleus - adult, donor10196	10182-103D2	20.27	7.87
locus coeruleus, adult, donor10252	10165-103B3	29.53	10.52
locus coeruleus, adult, donor10258	10375-105G6	8.46	7.62
locus coeruleus, newborn, donor10223	10362-105F2	29.86	8.83
lung adenocarcinoma cell line:A549	10499-107C4	22.97	9.96
lung adenocarcinoma cell line:PC-14	10408-106B3	39.30	14.48
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	17.80	11.47
lung, adult, pool1	10019-101D1	12.76	9.10
lung, fetal, donor1	10068-101I5	14.27	11.42
lung, right lower lobe, adult, donor1	10075-102A3	11.91	3.67
lymph node, adult, donor1	10077-102A5	11.36	6.63
lymphangiectasia cell line:DS-1	10727-110A7	9.42	7.45
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	22.49	13.43
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	39.93	11.04
mature adipocyte, donor1	12231-129F8	17.76	4.88
mature adipocyte, donor2	12232-129F9	18.68	7.06
mature adipocyte, donor3	12233-129G1	18.02	7.11
mature adipocyte, donor4	12234-129G2	18.69	8.95
maxillary sinus tumor cell line:HSQ-89	10414-106B9	87.44	23.83
medial frontal gyrus - adult, donor10196	10170-103B8	31.58	15.79
medial frontal gyrus, adult, donor10252	10150-102I6	40.28	12.14
medial frontal gyrus, adult, donor10258	10368-105F8	16.20	9.85
medial frontal gyrus, newborn, donor10223	10352-105E1	65.68	9.81
medial temporal gyrus - adult, donor10196	10183-103D3	26.33	12.32
medial temporal gyrus, adult, donor10252	10156-103A3	36.50	11.25
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	13.48
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	57.41
medial temporal gyrus, newborn, donor10223	10353-105E2	31.59	7.54
medulla oblongata - adult, donor10196	10174-103C3	6.49	3.24
medulla oblongata, adult, donor10252	10155-103A2	26.63	12.85
medulla oblongata, adult, pool1	10038-101F2	22.69	10.86
medulla oblongata, newborn, donor10223	10361-105F1	15.62	6.25
medulloblastoma cell line:D283 Med	10838-111E1	25.02	15.94
medulloblastoma cell line:ONS-76	10759-110E3	22.25	13.57
melanoma cell line:COLO 679	10514-107E1	26.45	8.77
melanoma cell line:G-361	10465-106H6	30.13	11.94
meningioma cell line:HKBMM	10691-109F7	15.74	5.97
merkel cell carcinoma cell line:MKL-1	10843-111E6	28.20	13.22
merkel cell carcinoma cell line:MS-1	10844-111E7	30.59	22.03
mesenchymal precursor cell - adipose, donor1	11747-123G1	22.25	12.89
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.18	11.63
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.84	8.70
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	18.12	10.25
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	11.94	10.98
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.19	14.58
mesenchymal precursor cell - cardiac, donor1	11752-123G6	25.40	12.87
mesenchymal precursor cell - cardiac, donor2	11753-123G7	15.41	8.17
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.72	11.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	16.74	16.07
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	22.48	14.94
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.17	8.23
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	16.60	8.58
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	13.61	8.38
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	19.19	7.55
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	26.24	9.35
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	13.86	8.69
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	23.26	7.07
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	30.63	18.46
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	20.47	10.91
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	18.29	12.95
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	17.67	8.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.89	8.58
mesenchymal stem cell line:Hu5/E18	10568-108B1	15.16	5.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	13.24	10.50
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	10.23	9.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.56	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.02	6.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	14.12	9.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	12.86	5.75
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.82	10.61
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	14.83	8.80
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	17.02	7.50
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	12.05	8.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	16.82	8.89
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	16.87	12.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	13.76	9.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	14.33	12.28
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.46	15.03
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	16.56	11.04
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	17.46	8.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	11.19	6.40
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	5.72
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	14.38	5.83
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	19.87	6.95
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.60	10.08
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	6.09
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.03	5.70
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.90	9.31
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	19.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	11.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	13.78
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.89	7.33
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	5.56	11.12
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	8.84	5.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	8.42	8.73
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	10.69
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	7.10	5.91
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	15.41
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.13	15.14
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.45	5.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	8.97	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	3.82	7.63
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	7.66	5.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	10.90
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	6.34
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	9.10	4.25
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.88	7.41
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.14	8.33
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	8.76	5.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	6.11
mesodermal tumor cell line:HIRS-BM	10696-109G3	14.70	6.19
mesothelioma cell line:ACC-MESO-1	10493-107B7	64.73	19.14
mesothelioma cell line:ACC-MESO-4	10494-107B8	15.75	8.34
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	14.80	6.99
mesothelioma cell line:Mero-25	10850-111F4	22.92	12.26
mesothelioma cell line:Mero-41	10851-111F5	22.98	9.05
mesothelioma cell line:Mero-48a	10852-111F6	25.02	9.52
mesothelioma cell line:Mero-82	10853-111F7	27.59	17.87
mesothelioma cell line:Mero-83	10854-111F8	17.87	11.92
mesothelioma cell line:Mero-84	10855-111F9	16.94	11.37
mesothelioma cell line:Mero-95	10856-111G1	26.92	14.08
mesothelioma cell line:NCI-H2052	10847-111F1	37.44	13.09
mesothelioma cell line:NCI-H226	10846-111E9	19.73	9.77
mesothelioma cell line:NCI-H2452	10848-111F2	24.77	12.98
mesothelioma cell line:NCI-H28	10845-111E8	15.78	12.72
mesothelioma cell line:No36	10857-111G2	22.18	14.35
mesothelioma cell line:ONE58	10858-111G3	27.37	8.94
migratory langerhans cells, donor1	11901-125F2	16.31	11.90
migratory langerhans cells, donor2	11902-125F3	17.34	9.53
migratory langerhans cells, donor3	11903-125F4	21.54	14.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	19.92	6.20
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	21.83	11.44
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	26.26	10.14
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	17.13	9.51
myelodysplastic syndrome cell line:SKM-1	10772-110F7	27.35	16.08
myeloma cell line:PCM6	10474-106I6	21.35	12.85
myxofibrosarcoma cell line:MFH-ino	10600-108E6	24.86	7.61
myxofibrosarcoma cell line:NMFH-1	10684-109E9	36.48	16.08
nasal epithelial cells, donor1, tech_rep1	12226-129F3	22.84	7.02
nasal epithelial cells, donor1, tech_rep2	12226-129F3	21.40	6.40
nasal epithelial cells, donor2	12227-129F4	18.22	6.07
neuroblastoma cell line:CHP-134	10508-107D4	40.72	22.78
neuroblastoma cell line:NB-1	10539-107G8	24.88	22.45
neuroblastoma cell line:NBsusSR	10607-108F4	30.37	9.91
neuroblastoma cell line:NH-12	10555-107I6	33.73	17.52
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	15.66	9.01
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	19.16	9.19
neuroectodermal tumor cell line:TASK1	10774-110F9	5.43	6.04
neuroepithelioma cell line:SK-N-MC	10728-110A8	8.90	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	7.72	5.59
neutrophil PMN, donor1	12133-128D9	14.87	0.00
neutrophil PMN, donor2	12137-128E4	13.28	26.56
neutrophil PMN, donor3	12141-128E8	47.35	18.94
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	41.10	30.78
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	22.41	14.41
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	9.62	7.69
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	21.81	13.40
nucleus accumbens, adult, pool1	10037-101F1	24.65	14.15
occipital cortex - adult, donor10196	10172-103C1	18.54	14.42
occipital cortex, adult, donor10252	10163-103B1	37.84	10.47
occipital cortex, newborn, donor10223	10355-105E4	47.68	6.19
occipital lobe, adult, donor1	10076-102A4	16.79	11.81
occipital lobe, fetal, donor1	10073-102A1	11.59	9.87
occipital pole, adult, pool1	10036-101E9	25.39	10.33
olfactory region, adult	10195-103E6	21.40	10.32
optic nerve, donor1	10277-104E7	20.01	10.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	29.05	12.53
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	44.93	16.62
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	28.28	10.84
oral squamous cell carcinoma cell line:SAS	10544-107H4	31.53	14.21
osteoclastoma cell line:Hs 706.T	10704-109H2	13.82	7.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	34.57	16.82
osteosarcoma cell line:HS-Os-1	10558-107I9	20.36	14.42
ovary, adult, pool1	10020-101D2	15.81	7.25
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	18.52	9.90
pancreas, adult, donor1	10049-101G4	43.27	37.63
pancreatic carcinoma cell line:NOR-P1	10698-109G5	24.04	13.42
papillary adenocarcinoma cell line:8505C	10437-106E5	39.35	26.06
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	24.67	10.60
paracentral gyrus, adult, pool1	10035-101E8	24.62	16.11
parietal cortex, adult, donor10258	10373-105G4	16.88	9.54
parietal lobe - adult, donor10196	10171-103B9	19.75	11.29
parietal lobe, adult, donor10252	10157-103A4	39.91	17.96
parietal lobe, adult, pool1	10034-101E7	27.41	15.33
parietal lobe, fetal, donor1	10072-101I9	15.52	9.70
parietal lobe, newborn, donor10223	10356-105E5	40.38	9.35
parotid gland, adult	10199-103F1	22.20	21.58
penis, adult	10200-103F2	18.26	4.30
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	25.85	8.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	25.06	15.30
pineal gland - adult, donor10196	10179-103C8	14.19	6.45
pineal gland, adult, donor10252	10160-103A7	26.06	16.58
pineal gland, adult, donor10258	10377-105G8	9.41	6.27
pituitary gland - adult, donor10196	10180-103C9	22.26	31.37
pituitary gland, adult, donor10252	10162-103A9	39.61	20.33
pituitary gland, adult, donor10258	10378-105G9	10.21	11.07
placenta, adult, pool1	10021-101D3	20.75	8.49
plasma cell leukemia cell line:ARH-77	10840-111E3	42.24	14.30
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	25.06	3.89
pons, adult, pool1	10033-101E6	23.24	14.03
postcentral gyrus, adult, pool1	10032-101E5	26.68	14.99
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	23.47
prostate cancer cell line:DU145	10490-107B4	18.50	10.63
prostate cancer cell line:PC-3	10439-106E7	23.60	16.34
prostate, adult, pool1	10022-101D4	13.79	9.70
putamen, adult, donor10196	10176-103C5	30.22	17.70
putamen, adult, donor10252	10152-102I8	17.65	17.65
putamen, adult, donor10258, tech_rep1	10372-105G3	5.46	13.11
putamen, adult, donor10258, tech_rep2	10372-105G3	21.50	8.94
putamen, newborn, donor10223	10365-105F5	57.72	6.75
rectal cancer cell line:TT1TKB	10469-106I1	33.75	8.15
rectum, fetal, donor1	10067-101I4	8.35	12.52
renal cell carcinoma cell line:OS-RC-2	10411-106B6	22.26	5.72
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	24.85	5.38
retina, adult, pool1	10030-101E3	18.99	8.85
retinoblastoma cell line:Y79	10475-106I7	18.71	13.77
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.82	8.73
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	25.03	13.78
sacrococcigeal teratoma cell line:HTST	10695-109G2	13.64	6.82
salivary acinar cells, donor1	11771-123I7	14.08	6.47
salivary acinar cells, donor2	11772-123I8	17.35	5.09
salivary acinar cells, donor3	11773-123I9	30.45	5.30
salivary gland, adult, pool1	10093-102C3	17.73	12.01
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	31.53	21.75
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	32.56	19.98
seminal vesicle, adult	10201-103F3	13.76	8.47
serous adenocarcinoma cell line:JHOS-2	10639-108I9	13.60	4.13
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	41.02	7.55
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	17.06	7.02
serous cystadenocarcinoma cell line:HTOA	10693-109F9	37.74	15.72
signet ring carcinoma cell line:Kato III	10436-106E4	28.18	7.63
signet ring carcinoma cell line:NUGC-4	10483-107A6	32.13	13.03
skeletal muscle - soleus muscle, donor1	10282-104F3	22.70	7.09
skeletal muscle, adult, pool1	10023-101D5	23.03	9.95
skeletal muscle, fetal, donor1	10066-101I3	11.06	9.05
skin, adult, donor1	10074-102A2	20.36	20.36
skin, fetal, donor1	10065-101I2	13.89	10.73
small cell cervical cancer cell line:HCSC-1	10800-110I8	52.36	23.68
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	25.53	13.55
small cell lung carcinoma cell line:DMS 144	10841-111E4	22.17	6.75
small cell lung carcinoma cell line:LK-2	10541-107H1	46.15	22.42
small cell lung carcinoma cell line:NCI-H82	10842-111E5	51.15	4.99
small cell lung carcinoma cell line:WA-hT	10562-108A4	52.52	25.06
small intestine, adult, pool1	10024-101D6	38.70	9.56
small intestine, fetal, donor1	10064-101I1	21.13	9.58
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	108.74	29.24
smooth muscle, adult, pool1	10048-101G3	12.92	8.79
somatostatinoma cell line:QGP-1	10781-110G7	24.93	17.96
spinal cord - adult, donor10196	10181-103D1	11.70	6.88
spinal cord, adult, donor10252	10159-103A6	16.56	7.89
spinal cord, adult, donor10258	10369-105F9	16.60	9.69
spinal cord, fetal, donor1	10056-101H2	8.54	8.54
spinal cord, newborn, donor10223	10359-105E8	27.09	12.40
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	12.84	7.17
spleen, adult, pool1	10025-101D7	13.22	8.92
spleen, fetal, pool1	10044-101F8	11.60	9.46
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.32	7.56
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	34.37	13.48
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	28.31	11.88
squamous cell carcinoma cell line:T3M-5	10616-108G4	43.00	10.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	79.13	18.46
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.56	8.05
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	19.46	10.58
stomach, fetal, donor1	10062-101H8	13.88	5.34
submaxillary gland, adult	10202-103F4	18.80	5.13
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	29.08	10.59
substantia nigra, adult, donor10258	10371-105G2	16.03	4.66
substantia nigra, newborn, donor10223	10358-105E7	12.72	4.95
synovial sarcoma cell line:HS-SY-II	10441-106E9	29.35	18.80
temporal lobe, adult, pool1	10031-101E4	26.70	11.78
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	19.23	7.83
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	18.46	12.31
tenocyte, donor1	11763-123H8	15.71	12.57
tenocyte, donor2	11765-123I1	15.64	7.63
tenocyte, donor3	11768-123I4	14.46	11.12
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	17.34	23.62
teratocarcinoma cell line:NCR-G1	10798-110I6	22.20	16.96
teratocarcinoma cell line:PA-1	10807-111A6	8.37	8.68
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	11.93	10.92
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	22.69	14.37
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	41.77	44.82
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	47.88	34.52
testis, adult, pool1	10026-101D8	18.47	8.70
testis, adult, pool2	10096-102C6	26.61	9.02
thalamus - adult, donor10196	10168-103B6	17.66	3.31
thalamus, adult, donor10252	10154-103A1	35.32	10.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	13.86	15.40
thalamus, adult, donor10258, tech_rep2	10370-105G1	8.40	4.61
thalamus, newborn, donor10223	10366-105F6	26.46	6.90
throat, adult	10209-103G2	17.23	8.74
throat, fetal, donor1	10061-101H7	8.53	7.92
thymic carcinoma cell line:Ty-82	10803-111A2	19.48	6.36
thymus, adult, pool1	10027-101D9	20.08	9.84
thymus, fetal, pool1	10043-101F7	21.09	9.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	22.34	12.76
thyroid carcinoma cell line:TCO-1	10783-110G9	26.26	20.53
thyroid, adult, pool1	10028-101E1	19.78	17.73
thyroid, fetal, donor1	10060-101H6	10.55	9.23
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	6.16
tongue, adult	10203-103F5	14.42	6.51
tongue, fetal, donor1	10059-101H5	13.79	5.52
tonsil, adult, pool1	10047-101G2	23.64	13.52
trachea, adult, pool1	10029-101E2	15.62	7.53
trachea, fetal, donor1	10058-101H4	13.08	7.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	13.11	11.69
transitional-cell carcinoma cell line:5637	10418-106C4	20.26	14.69
transitional-cell carcinoma cell line:JMSU1	10492-107B6	39.49	17.24
tridermal teratoma cell line:HGRT	10694-109G1	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	14.05	7.45
umbilical cord, fetal, donor1	10057-101H3	16.69	16.69
uterus, adult, pool1	10100-102D1	18.43	10.75
uterus, fetal, donor1	10055-101H1	10.24	11.77
vagina, adult	10204-103F6	12.92	12.92
vein, adult	10191-103E2	12.93	7.67
xeroderma pigentosum b cell line:XPL 17	10563-108A5	16.29	14.15